CardioDx, Inc. Aims for $92 Million IPO
California's CardioDx details the structure of its $92 million initial public offering, going for $14-$16 per share. CardioDx aims for $92M IPO. California molecular diagnostics company CardioDx unveiled new details of its initial public offering, slated to raise $92 million through shares priced at $14-$16 apiece. Once the IPO launches, CardioDx will trade on the Nasdaq stock market under the symbol "CDX."
Help employers find you! Check out all the jobs and post your resume.